Form 8-K · Current Report · Filed 2026-07-23
Thermo Fisher Scientific Reports Strong Q2 2026 Financial Results
Thermo Fisher Scientific Inc. reported its financial results for the second quarter of 2026, showing a 10% increase in revenue to $11.99 billion. The company achieved 9% growth in GAAP diluted earnings per share (EPS) to $4.68 and 13% growth in adjusted EPS to $6.03. Organic revenue growth was 5%. The company advanced its growth strategy by launching new products and strengthening its commercial engine. Capital deployment included the divestiture of the microbiology business and the repurchase of $1.0 billion of stock.
- Filer
- Thermo Fisher Scientific Inc. TMO · NYSE
- Filed
- Accession
- 0000097745-26-000138
- CIK
- 0000097745
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$526.46
Next session
+7.9%
Since filing
+9.1%
Latest close
$574.30
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from TMO reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, TMO insiders reported 6 Form 4 transactions — net selling of $226K.
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.
Never miss another TMO filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.